Symposium on

Cancer genomics and epitranscriptomics:
from the bench to the clinic

With the advent of massive sequencing, bioinformatics and machine learning approaches, we have witnessed a rapid expansion of the understanding of biological processes at the genomics, epigenetics and epitranscriptomics level in recent years. This has promoted changes in paradigms in several areas such as evo-devo, stem cell biology, and cancer research.

The goal of this international symposium is to provide a comprehensive overview of the impact of these technologies and scientific advanced in cancer both at the basic and clinical level, trigger discussions on current topics, and foster the assembly of international collaborations.

The Symposium also includes educational sessions for both early investigators (grad students, postdocts) and principal investigators.

Targeted audience include university students, early investigators (PhD students, postdoc) as well as established basic and clinical investigators.

Please, join us!